SeaStar Medical Holding (ICU) Amortization of Deferred Charges (2023 - 2026)
SeaStar Medical Holding's (ICU) quarterly Amortization of Deferred Charges came in at $6000.0 in Q1 2026, down 45.45% YoY from $11000.0 in Q1 2025, and down 14.29% on a QoQ basis from $7000.0 in Q2 2025.
SeaStar Medical Holding (ICU) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 4 years of Amortization of Deferred Charges data on file, last reported at $6000.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges fell 45.45% year-over-year to $6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13000.0 (down 84.88% YoY) and the FY2025 annual result came in at $18000.0, down 82.35% from the prior year.
- Amortization of Deferred Charges eased to $6000.0 in Q1 2026, from $7000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $45000.0 in Q3 2024 to a low of $4000.0 in Q1 2023.
- A 4-year average of $17400.0 and a median of $12500.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2024 — Amortization of Deferred Charges jumped 575.0% — and 2025, when it sank 76.67%.
- Tracing ICU's Amortization of Deferred Charges over 4 years: stood at $11000.0 in 2023, then surged by 309.09% to $45000.0 in 2024, then sank by 84.44% to $7000.0 in 2025, then decreased by 14.29% to $6000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $6000.0 (Q1 2026), $7000.0 (Q2 2025), and $11000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8,000.00 |
| Jun 30, 2026 | 8,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Sep 30, 2024 | 45,000.00 |
| Sep 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 19,000.00 |